Position in ABOS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$190,806
+$150,716 QoQ
Shares Held
80,850
+325.5% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#33
of 84 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in ABOS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PFG Investments, LLC holds $8,383,926 across 23 Biotechnology names. ABOS ranks #13 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ADMA |
Adma Biologics, Inc.
|
222,729 | $2,006,788 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,134 | $952,916 | |
| 3 | ARDX |
Ardelyx, Inc.
|
137,860 | $825,781 | |
| 4 | NGEN |
Nervgen Pharma Corp.
|
201,000 | $757,770 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
44,890 | $665,269 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
7,725 | $573,658 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
20,843 | $453,543 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
1,455 | $432,091 |
All Filings in ABOS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $190,806 | 80,850 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $40,090 | 19,000 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $19,665 | 11,500 | Shares | Sole | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||